Home Research-feed Channel Rankings GCT THU AI TR Open Data Must Reading

views: 5

Michael A. Pacanowski

Department of Pharmacy Practice and Center for Pharmacogenomics, University of Florida College of Medicine, PO Box 100486, Gainesville, FL 32610, USA

Sign in to view more

Show Academic Trajectory

Ego Network

D-Core

Research Interests

Author Statistics

Experience

Education

Bio

None

Papers30 papers

Sort

By YearBy Citation

Thromboembolic and hemorrhagic outcomes in the direct oral anticoagulant trials across the spectrum of kidney function

Nita A Limdi,T Mark Beasley, Jielin Sun,Norman Stockbridge,Michael Pacanowski,Jeffry Florian

Clinical pharmacology and therapeutics, (2020)

WOSBibtex

Precision Medicine 2030

Michael Pacanowski, Qi Liu

Clinical pharmacology and therapeutics, (2019)

WOSBibtex

Evolution of Next Generation Therapeutics: Past, Present, and Future of Precision Medicines

Anuradha Ramamoorthy,Jason H Karnes, Richard Finkel, Rebecca Blanchard,Michael Pacanowski

Clinical and translational science, (2019)

WOSBibtex

An Overview of Genomic Biomarker Use in Cardiovascular Disease Clinical Trials

Oluseyi Adeniyi,Anuradha Ramamoorthy,Robert Schuck, Jielin Sun, Jennifer Wilson,Issam Zineh,Michael Pacanowski

Clinical pharmacology and therapeutics, (2019)

WOSBibtex

Use of Titration as a Therapeutic Individualization Strategy: An Analysis of Food and Drug Administration-Approved Drugs

Robert N Schuck,Michael Pacanowski, Sarah Kim,Rajanikanth Madabushi,Issam Zineh

Clinical and translational science, (2019)

WOSBibtex

Gel Aqua Women's ASICS Diva White 7 Tennis Resolution Shoe Blue Splash qYHY5TFx at uber-traffic.com

Katarzyna Drozda,Michael A. Pacanowski, Christian Grimstein, Issam Zineh

JACC: Basic to Translational Science, no. 4 (2018): 545-549

Bibtex

PathFX provides mechanistic insights into drug efficacy and safety for regulatory review and therapeutic development

Jennifer L Wilson,Rebecca Racz,Tianyun Liu, Oluseyi Adeniyi, Jielin Sun,Anuradha Ramamoorthy,Michael Pacanowski,Russ Altman

PLoS computational biology, no. 12 (2018)

WOSBibtex

Demographic Composition of Select Oncologic New Molecular Entities Approved by the FDA Between 2008 and 2017

Anuradha Ramamoorthy, Todd C Knepper, Christine Merenda, Martin Mendoza,Howard L McLeod,Jonca Bull,Lei Zhang,Michael Pacanowski

Clinical pharmacology and therapeutics, (2018)

WOSBibtex

Considerations for Developing Targeted Therapies in Low-Frequency Molecular Subsets of a Disease

Robert N Schuck,Janet Woodcock,Issam Zineh, Peter Stein, Jonathan Jarow,Robert Temple, Thomas Permutt,Lisa LaVange, Julia A Beaver,Rosane Charlab,Gideon M Blumenthal,Sarah E Dorff

Clinical pharmacology and therapeutics, (2018)

Cited by1WOSBibtex

Pharmacogenetic Labeling of FDA-Approved Drugs: A Regulatory Retrospective

Katarzyna Drozda,Michael A. Pacanowski, Christian Grimstein,Issam Zineh

JACC: Basic to Translational Science, no. 4 (2018): 545-549

Cited by2Bibtex

Enrichment Strategies in Pediatric Drug Development: An Analysis of Trials Submitted to the US Food and Drug Administration

Dionna J Green, Xiaomei I Liu, Tianyi Hua, Janelle M Burnham,Robert Schuck,Michael Pacanowski,Lynne Yao, Susan K McCune,Gilbert J Burckart,Issam Zineh

Clinical pharmacology and therapeutics, (2017)

WOSBibtex

Clinical Trial Designs to Support Clinical Utility of Pharmacogenomic Testing

Katarzyna Drozda,Michael A. Pacanowski

Pharmacotherapy, no. 9 (2017): 1000-1004

Cited by3Bibtex

Regulatory policy for the development of targeted therapies for low-frequency molecular subtypes of disease

Robert N Schuck,Michael Pacanowski,Janet Woodcock,Issam Zineh

Nature reviews. Drug discovery, (2017)

Cited by1WOSBibtex

Pharmacogenomic information in FDA-approved drug labels: Application to pediatric patients

D J Green,P Mummaneni,I W Kim,J M Oh,M Pacanowski,G J Burckart

Clinical pharmacology and therapeutics, no. 6 (2016): 622-32

WOSBibtex

Clinical and regulatory considerations in pharmacogenetic testing

Robert N. Schuck, Elizabeth Marek,Hobart Rogers,Michael A. Pacanowski

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, no. 23 (2016): 1999-2006

Bibtex

How Informative Are Drug-Drug Interactions of Gene-Drug Interactions

Chakradhar V. Lagishetty, Jiexin Deng,Lawrence J. Lesko,Hobart Rogers,Michael Pacanowski,Stephan Schmidt

The Journal of Clinical Pharmacology, no. 10 (2016): 1221-1231

Bibtex

Precision Medicine

M Pacanowski, S M Huang

Clinical pharmacology and therapeutics, no. 2 (2016): 124-129

Cited by4WOSBibtex

Dosing recommendations for pharmacogenetic interactions related to drug metabolism

Kelly K Filipski,Michael A Pacanowski,Anuradha Ramamoorthy,William Gregory Feero,Andrew N Freedman

Pharmacogenetics and genomics, (2016)

WOSBibtex

Pharmacogenomic Information in FDA‐Approved Drug Labels: Application to Pediatric Patients

Dionna J Green,Padmaja Mummaneni,Inwha Kim,Jung Mi Oh,Michael A Pacanowski,Gilbert J Burckart

Clinical Pharmacology & Therapeutics, (2015)

Bibtex

Precision Medicine in the Age of Big Data: The Present and Future Role of Large Scale Unbiased Sequencing in Drug Discovery and Development

Paolo Vicini, Owen Fields, Eric Lai, E David Litwack, Annemarie Martin, Thomas M Morgan,M A Pacanowski,Marisa Papaluca, Omar D Perez, Michael S Ringel,Matthew D Robson,Hakan Sakul

Clinical pharmacology and therapeutics, (2015)

Cited by43WOSBibtex

View All

Base Info Papers Patents Projects